LIVER TOXICITY IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA TREATED WITH PAZOPANIB THERAPY

被引：0
|
作者：
Lim, F. L. [1 ]
Shamash, J. [2 ]
Wilson, P. [2 ]
Powles, T. [3 ]
机构：
[1] St Bartholomews Hosp, Dept Med Oncol, London, England
[2] Barts Canc Insititute, QMUL, London, England
[3] St Bartholomews Hosp QMUL, Barts Canc Inst, London, England
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：290 / 290
页数：1
相关论文
共 50 条
  • [1] Liver toxicity in patients with metastatic renal cell carcinoma treated with pazopanib therapy
    Lim, L.
    Mathias, J.
    Lampron, M.
    Fehr, M.
    Gruenwald, V.
    Khan, M.
    Crabb, S.
    Choueiri, T.
    Powles, T.
    Rini, B.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S660 - S660
  • [2] Treatment-associated liver-toxicity in patients with advanced metastatic renal cell carcinoma (mRCC) treated with Pazopanib
    Rickmann, M.
    Seidel, C.
    Reuter, C.
    Trummer, A.
    Ganser, A.
    Gruenwald, V
    [J]. ONKOLOGIE, 2013, 36 : 76 - 77
  • [3] Outcomes of unselected patients with metastatic renal cell carcinoma treated with front-line pazopanib therapy
    Matrana, M.
    Shetty, A.
    Teegavarapu, R.
    Kalra, S.
    Xiao, L.
    Atkinson, B.
    Corn, P.
    Jonasch, E.
    Tannir, N. M.
    [J]. EUROPEAN JOURNAL OF CANCER, 2013, 49 : S668 - S669
  • [4] Sequential Targeted Therapy After Pazopanib Therapy in Patients With Metastatic Renal Cell Cancer: Efficacy and Toxicity
    Bellmunt, Joaquim
    Pons, Francesc
    Foreshew, Abigail
    Fay, Andre P.
    Powles, Thomas
    Porta, Camillo
    Bracarda, Sergio
    Lampron, Megan E.
    Cerbone, Linda
    Sternberg, Cora N.
    Hutson, Thomas E.
    Choueiri, Toni K.
    [J]. CLINICAL GENITOURINARY CANCER, 2014, 12 (04) : 262 - 269
  • [5] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?
    Ronald M. Bukowski
    [J]. Current Oncology Reports, 2010, 12 : 77 - 79
  • [6] Is Pazopanib Safe and Efficacious in Patients with Metastatic Renal Cell Carcinoma?
    Bukowski, Ronald M.
    [J]. CURRENT ONCOLOGY REPORTS, 2010, 12 (02) : 77 - 79
  • [7] Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
    Hutson, Thomas E.
    Davis, Ian D.
    Machiels, Jean-Pascal H.
    De Souza, Paul L.
    Rottey, Sylvie
    Hong, Bao-fa
    Epstein, Richard J.
    Baker, Katherine L.
    McCann, Lauren
    Crofts, Theresa
    Pandite, Lini
    Figlin, Robert A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (03) : 475 - 480
  • [8] Inflammatory response as a novel prognostic parameter in patients with metastatic renal cell carcinoma treated with pazopanib
    Lingerfelt, Brian M.
    Akbashev, Mikhail Y.
    Master, Viraj A.
    Harris, Wayne B.
    [J]. CANCER RESEARCH, 2012, 72
  • [9] Nursing Considerations With Pazopanib Therapy: Focus on Metastatic Renal Cell Carcinoma
    Bourdeanu, Laura
    Twardowski, Przemyslaw
    Pal, Sumanta Kumar
    [J]. CLINICAL JOURNAL OF ONCOLOGY NURSING, 2011, 15 (05) : 513 - 517
  • [10] Pazopanib for the Treatment of Metastatic Renal Cell Carcinoma
    Pick, Amy M.
    Nystrom, Kelly K.
    [J]. CLINICAL THERAPEUTICS, 2012, 34 (03) : 511 - 520
12345